Enalare Therapeutics is a clinical stage biopharmaceutical company dedicated to developing novel therapies.
Enalare Therapeutics has raised $2.5M in total funding. The most recent round was Grant. The last funding was announced in January 2025.
Enalare Therapeutics's investors include NJEDA, Eagle Pharmaceuticals, Biomedical Advanced Research and Development Authority (BARDA), National Institute on Drug Abuse (NIDA).
Enalare Therapeutics is headquartered in Naples, United States.
Enalare Therapeutics is a clinical stage biopharmaceutical company dedicated to developing novel therapies.
Enalare Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Enalare Therapeutics — Funding & Investors." VCBacked, January 30, 2025, https://www.vcbacked.co/company/enalare-therapeutics. Accessed August 14, 2026.
VCBacked. (2025). Enalare Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/enalare-therapeutics
{{cite web |title=Enalare Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/enalare-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated